Xenobiotic, bile acid, and cholesterol transporters: function and regulation
CD Klaassen, LM Aleksunes - Pharmacological reviews, 2010 - ASPET
Transporters influence the disposition of chemicals within the body by participating in
absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) …
absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) …
Role of P-glycoprotein in pharmacokinetics: clinical implications
JH Lin, M Yamazaki - Clinical pharmacokinetics, 2003 - Springer
P-glycoprotein, the most extensively studied ATP-binding cassette (ABC) transporter,
functions as a biological barrier by extruding toxins and xenobiotics out of cells. In vitro and …
functions as a biological barrier by extruding toxins and xenobiotics out of cells. In vitro and …
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
CH Choi - Cancer cell international, 2005 - Springer
One of the major problems related with anticancer chemotherapy is resistance against
anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter …
anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter …
The role of ABC transporters in drug resistance, metabolism and toxicity
H Glavinas, P Krajcsi, J Cserepes… - Current drug …, 2004 - ingentaconnect.com
ATP Binding Cassette (ABC) transporters form a special family of membrane proteins,
characterized by homologous ATP-binding, and large, multispanning transmembrane …
characterized by homologous ATP-binding, and large, multispanning transmembrane …
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery
J Cory Kalvass, TS Maurer - Biopharmaceutics & drug …, 2002 - Wiley Online Library
Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in
plasma and brain were examined for 18 proprietary compounds in rats. The relationship …
plasma and brain were examined for 18 proprietary compounds in rats. The relationship …
Pluronic® block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers
AV Kabanov, VY Alakhov - Critical Reviews™ in Therapeutic …, 2002 - dl.begellhouse.com
Pluronicв block copolymers are recognized pharmaceutical excipients listed in the US and
British Pharmacopoeia. The incorporation of drugs into Pluronic micelles results in …
British Pharmacopoeia. The incorporation of drugs into Pluronic micelles results in …
Expression and function of efflux drug transporters in the intestine
M Takano, R Yumoto, T Murakami - Pharmacology & therapeutics, 2006 - Elsevier
A variety of drug transporters expressed in the body control the fate of drugs by affecting
absorption, distribution, and elimination processes. In the small intestine, transporters …
absorption, distribution, and elimination processes. In the small intestine, transporters …
In vitro and in vivo P-glycoprotein transport characteristics of rivaroxaban
MJ Gnoth, U Buetehorn, U Muenster, T Schwarz… - … of Pharmacology and …, 2011 - ASPET
Rivaroxaban, an oral, direct factor Xa inhibitor, has a dual mode of elimination in humans,
with two-thirds metabolized by the liver and one-third renally excreted unchanged. P …
with two-thirds metabolized by the liver and one-third renally excreted unchanged. P …
Improving cancer chemotherapy with modulators of ABC drug transporters
S Shukla, S Ohnuma, SV Ambudkar - Current drug targets, 2011 - ingentaconnect.com
ATP-binding cassette (ABC) transporters, P-glycoprotein (P-gp, ABCB1) and ABCG2, are
membrane proteins that couple the energy derived from ATP hydrolysis to efflux many …
membrane proteins that couple the energy derived from ATP hydrolysis to efflux many …
Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier
Drug efflux transporters can influence the absorption, tissue distribution and elimination of
many therapeutic agents. Modulation of drug efflux transporter activity is being explored as a …
many therapeutic agents. Modulation of drug efflux transporter activity is being explored as a …